GERALD LELAIS,ROBERT EPPLE,THOMAS H. MARSILJE III,PIERRE-YVES MICHELLYS,MATTHEW H. MCNEILL,YUN LONG,WENSHUO LU,BEI CHEN,BADRY BURSULAYA,SONGCHUN JIANG
申请号:
PT13729219
公开号:
PT2773635T
申请日:
2013.06.05
申请国别(地区):
PT
年份:
2017
代理人:
摘要:
The invention provides compounds and pharmaceutical compositions thereof, which are useful for modulating EGFR activity, as well as methods for using such compounds to treat, ameliorate or prevent a condition associated with abnormal or deregulated EGFR activity.